Copyright STAT
BERLIN — The leading professional organization for European oncologists has rolled out its first set of guidance on how its members should use large language models, a type of artificial intelligence, in cancer medicine. “The oncology community cannot ignore the potential benefits which AI technology can provide to cancer patients,” the authors of the guidance wrote, while simultaneously acknowledging that there aren’t enough evaluations of the chatbots available to patients or tools available to doctors to address the risks associated with generative AI in medicine. Advertisement
